Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
streptococci
on recurrences of acute and secretory otitis media in children:
randomised placebo controlled trial
Kristian Roos a Ear, Nose, and Throat Department, Lundby Hospital,
41717 Gothenburg, Sweden, b Department of Clinical Bacteriology, University of
Umeå, 90187 Umeå, Sweden, c Department of Clinical
Microbiology, University of Umeå
Correspondence to: K Roos kristian.roos{at}lundbysjukhus.se
Objective:
To study the effect of recolonisation with
streptococci with the ability to inhibit the growth of otopathogens ("interfering" activity) on the recurrence of acute otitis media in
susceptible children and the effect on the frequency of secretory otitis media.
Design:
Double blind, randomised, placebo controlled study.
Setting:
Ear, nose, and throat clinic with three doctors.
Participants:
130 children prone to otitis media aged
between 6 months and 6 years, 108 of whom were eligible and followed
for 3 months.
Main outcome measures:
Recurrence of otitis media
during follow up and a normal tympanic membrane at the last valid visit.
Interventions:
Children with no recurrences during the
last month received phenoxymethylpenicillin (n=22), and those with a
recurrence within 1 month received amoxicillin clavulanic acid (n=86),
both twice daily for 10 days. These were followed by a streptococcal or
placebo solution sprayed into the nose for a further 10 days. At day 60 the same spray was started for another 10 days.
Results:
At 3 months 22 children (42%) given the
streptococcal spray were healthy and had a normal tympanic membrane
compared with 12 (22%) of those given placebo. This difference was
shown separately for recurrences of both acute otitis media and
secretory otitis media.
Conclusions:
Selected bacteria with the ability to
inhibit the growth of common otopathogens can be used to protect
against recurrent acute otitis media and secretory otitis media in children.
Streptococci and recurrences of otitis media
Read all Rapid Responses